Revolution Medicines, Inc. (RVMD)
208.03
+2.46
(+1.20%)
USD |
NASDAQ |
Sep 01, 14:54
Revolution Medicines Total Long Term Debt (Quarterly) : 1.174B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.174B |
| March 31, 2026 | 420.66M |
| December 31, 2025 | 410.68M |
| September 30, 2025 | 142.14M |
| June 30, 2025 | 119.70M |
| March 31, 2025 | 121.36M |
| December 31, 2024 | 122.97M |
| September 30, 2024 | 78.31M |
| June 30, 2024 | 79.08M |
| March 31, 2024 | 79.86M |
| December 31, 2023 | 80.58M |
| September 30, 2023 | 57.09M |
| June 30, 2023 | 57.54M |
| March 31, 2023 | 57.68M |
| December 31, 2022 | 57.43M |
| September 30, 2022 | 58.18M |
| Date | Value |
|---|---|
| June 30, 2022 | 58.92M |
| March 31, 2022 | 59.58M |
| December 31, 2021 | 60.42M |
| September 30, 2021 | 26.83M |
| June 30, 2021 | 27.57M |
| March 31, 2021 | 28.29M |
| December 31, 2020 | 29.01M |
| September 30, 2020 | 29.73M |
| June 30, 2020 | 30.44M |
| March 31, 2020 | 7.553M |
| December 31, 2019 | 0.172M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.147M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 29.05M |
| Erasca, Inc. | 39.27M |
| Moderna, Inc. | 1.266B |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Intellia Therapeutics, Inc. | 50.07M |